Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 07, 2022

Abatacept for GVHD Prophylaxis Reduces the Impact of Mismatching in Unrelated Donor Stem Cell Transplantation

Blood Advances


Additional Info

Blood Advances
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation
Blood Adv 2022 Feb 08;6(3)746-749, M Qayed, B Watkins, S Gillespie, B Bratrude, K Betz, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, M Norkin, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, EK Waller, A Langston, LS Kean, JT Horan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading